Last reviewed · How we verify

LhRH-antagonist — Competitive Intelligence Brief

LhRH-antagonist (LhRH-antagonist) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: GnRH/LhRH antagonist. Area: Oncology.

marketed GnRH/LhRH antagonist GnRH receptor (LhRH receptor) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

LhRH-antagonist (LhRH-antagonist) — Turku University Hospital. LhRH antagonists block luteinizing hormone-releasing hormone receptors to suppress gonadotropin secretion and reduce sex hormone production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LhRH-antagonist TARGET LhRH-antagonist Turku University Hospital marketed GnRH/LhRH antagonist GnRH receptor (LhRH receptor)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (GnRH/LhRH antagonist class)

  1. Turku University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LhRH-antagonist — Competitive Intelligence Brief. https://druglandscape.com/ci/lhrh-antagonist. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: